These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18446475)

  • 1. Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.
    Bahl D; Bogner RH
    AAPS PharmSciTech; 2008; 9(1):146-53. PubMed ID: 18446475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
    Bahl D; Bogner RH
    Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
    Bahl D; Hudak J; Bogner RH
    Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH; Parikh JR; Parikh RH; Solanki AB
    AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution studies of physical mixtures of indomethacin with alpha- and gamma-cyclodextrins.
    Vranić E; Uzunović A
    Bosn J Basic Med Sci; 2010 Aug; 10(3):197-203. PubMed ID: 20846125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
    Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
    AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
    Grobelny P; Kazakevich I; Zhang D; Bogner R
    Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
    Dugar RP; Gajera BY; Dave RH
    AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
    Allahham A; Stewart PJ
    Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
    Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling.
    Al-Hamidi H; Edwards AA; Douroumis D; Asare-Addo K; Nayebi AM; Reyhani-Rad S; Mahmoudi J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Mar; 103():189-99. PubMed ID: 23201737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
    Tay T; Allahham A; Morton DA; Stewart PJ
    Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.